FDA NDC

ZIOPTAN

This name is from the loaded FDA file.

Source: FDA NDC Directory, live from openFDA. Publisher page

NDC
82584-609
Proprietary name
ZIOPTAN
Nonproprietary name
Tafluprost
Labeler
Thea Pharma Inc.
Dosage form
SOLUTION/ DROPS
Strength
.015 mg/mL

Run it in Rivvi

Which 2027 plans near you dropped or restricted Tafluprost?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Try it on your own data today.

Free to start. Most teams are using it the same day.